155 related articles for article (PubMed ID: 34633138)
1. miR-424/503 modulates Wnt/β-catenin signaling in the mammary epithelium by targeting LRP6.
Nekritz EA; Rodriguez-Barrueco R; Yan KK; Davis ML; Werner RL; Devis-Jauregui L; Mukhopadhyay P; Yu J; Llobet-Navas D; Silva J
EMBO Rep; 2021 Dec; 22(12):e53201. PubMed ID: 34633138
[TBL] [Abstract][Full Text] [Related]
2. MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists.
Lv C; Li F; Li X; Tian Y; Zhang Y; Sheng X; Song Y; Meng Q; Yuan S; Luan L; Andl T; Feng X; Jiao B; Xu M; Plikus MV; Dai X; Lengner C; Cui W; Ren F; Shuai J; Millar SE; Yu Z
Nat Commun; 2017 Oct; 8(1):1036. PubMed ID: 29051494
[TBL] [Abstract][Full Text] [Related]
3. Both LRP5 and LRP6 receptors are required to respond to physiological Wnt ligands in mammary epithelial cells and fibroblasts.
Goel S; Chin EN; Fakhraldeen SA; Berry SM; Beebe DJ; Alexander CM
J Biol Chem; 2012 May; 287(20):16454-66. PubMed ID: 22433869
[TBL] [Abstract][Full Text] [Related]
4. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
[TBL] [Abstract][Full Text] [Related]
5. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.
Lu W; Lin C; Li Y
Cell Signal; 2014 Jun; 26(6):1303-9. PubMed ID: 24607787
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer.
Zhu H; Su Z; Ning J; Zhou L; Tan L; Sayed S; Song J; Wang Z; Li H; Sun Q; Liu S; Sha O; Leng F; Chen X; Lu D
Cell Death Dis; 2021 Oct; 12(10):912. PubMed ID: 34615853
[TBL] [Abstract][Full Text] [Related]
7. Mature miR-183, negatively regulated by transcription factor GATA3, promotes 3T3-L1 adipogenesis through inhibition of the canonical Wnt/β-catenin signaling pathway by targeting LRP6.
Chen C; Xiang H; Peng YL; Peng J; Jiang SW
Cell Signal; 2014 Jun; 26(6):1155-65. PubMed ID: 24556500
[TBL] [Abstract][Full Text] [Related]
8. Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
Bonetti P; Climent M; Panebianco F; Tordonato C; Santoro A; Marzi MJ; Pelicci PG; Ventura A; Nicassio F
Oncogene; 2019 Jan; 38(3):360-374. PubMed ID: 30093634
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
10. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
Zhang J; Li Y; Liu Q; Lu W; Bu G
Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
[TBL] [Abstract][Full Text] [Related]
11. Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling.
Ahn Y; Sims C; Logue JM; Weatherbee SD; Krumlauf R
Development; 2013 Feb; 140(3):583-93. PubMed ID: 23293290
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N
Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321
[TBL] [Abstract][Full Text] [Related]
13. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
[TBL] [Abstract][Full Text] [Related]
14. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
[TBL] [Abstract][Full Text] [Related]
15. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
[TBL] [Abstract][Full Text] [Related]
16. Chromatin effector Pygo2 mediates Wnt-notch crosstalk to suppress luminal/alveolar potential of mammary stem and basal cells.
Gu B; Watanabe K; Sun P; Fallahi M; Dai X
Cell Stem Cell; 2013 Jul; 13(1):48-61. PubMed ID: 23684539
[TBL] [Abstract][Full Text] [Related]
17. Developmental stage and time dictate the fate of Wnt/β-catenin-responsive stem cells in the mammary gland.
van Amerongen R; Bowman AN; Nusse R
Cell Stem Cell; 2012 Sep; 11(3):387-400. PubMed ID: 22863533
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion.
Tung EK; Wong BY; Yau TO; Ng IO
PLoS One; 2012; 7(5):e36565. PubMed ID: 22570728
[TBL] [Abstract][Full Text] [Related]
19. VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6.
Dong Y; Zhang Y; Kang W; Wang G; Chen H; Higashimori A; Nakatsu G; Go M; Tong JH; Zheng S; To KF; Sung JJ; Yang X; Ng SS; Yu J
Theranostics; 2019; 9(22):6517-6531. PubMed ID: 31588233
[TBL] [Abstract][Full Text] [Related]
20. miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.
Wen Q; Zhao J; Bai L; Wang T; Zhang H; Ma Q
Oncol Rep; 2015 Oct; 34(4):2202-10. PubMed ID: 26239517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]